ITGA3 and glioblastoma: To gain a preliminary understanding as to whether α3β1 integrin may relate to malignancy and be of value as a therapeutic target, we examined GBM patient overall survival in relation to integrin α3 (ITGA3) gene expression in the TCGA database [33].